Skip to main content

Advertisement

ADVERTISEMENT

Videos

Yating Wang, MD
Videos
09/27/2024
Yating Wang, MD, shares the findings and future implications of her study on survival trends among patients with metastatic non–small cell lung cancer (NSCLC) before and after the approval of immunotherapy in the US.
Yating Wang, MD, shares the findings and future implications of her study on survival trends among patients with metastatic non–small cell lung cancer (NSCLC) before and after the approval of immunotherapy in the US.
Yating Wang, MD, shares the...
09/27/2024
Journal of Clinical Pathways
Alexander Spira, MD, PhD
Videos
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
Journal of Clinical Pathways

Advertisement

Luke Pike, MD
Videos
09/18/2024
Luke Pike, MD, shares key takeaways from the TURBO-Non–Small Cell Lung Cancer study and highlights promising studies on the horizon for EGFR mutant NSCLC treatment.
Luke Pike, MD, shares key takeaways from the TURBO-Non–Small Cell Lung Cancer study and highlights promising studies on the horizon for EGFR mutant NSCLC treatment.
Luke Pike, MD, shares key...
09/18/2024
Journal of Clinical Pathways
Jamie Chaft, MD, Memorial Sloan Kettering Cancer Center
Videos
09/17/2024
Jamie Chaft, MD, discusses the 5-year follow-up data from the IMpower010 trial which showed atezolizumab continued to provide greater improvement to disease-free survival than best supportive care for patients with resectable early-stage...
Jamie Chaft, MD, discusses the 5-year follow-up data from the IMpower010 trial which showed atezolizumab continued to provide greater improvement to disease-free survival than best supportive care for patients with resectable early-stage...
Jamie Chaft, MD, discusses the...
09/17/2024
Oncology
Steven Narod, MD, University of Toronto
Videos
09/12/2024
Steve Narod, MD, discusses the incidence of endometrial cancer among people who are BRCA mutation carriers.
Steve Narod, MD, discusses the incidence of endometrial cancer among people who are BRCA mutation carriers.
Steve Narod, MD, discusses the...
09/12/2024
Oncology

Advertisement

Luke Pike, MD
Videos
09/05/2024
Luke Pike, MD, breaks down the TURBO-Non–Small Cell Lung Cancer study and summarizes the main findings.
Luke Pike, MD, breaks down the TURBO-Non–Small Cell Lung Cancer study and summarizes the main findings.
Luke Pike, MD, breaks down the...
09/05/2024
Journal of Clinical Pathways
Alessandro Santin, MD, Yale Cancer Center
Videos
09/05/2024
Alessandro Santin, MD, shares insights from the endometrial cancer cohort of the TROPiCS-03 trial, which evaluated sacituzumab govetican among patients with advanced endometrial cancer who have been heavily pretreated.
Alessandro Santin, MD, shares insights from the endometrial cancer cohort of the TROPiCS-03 trial, which evaluated sacituzumab govetican among patients with advanced endometrial cancer who have been heavily pretreated.
Alessandro Santin, MD, shares...
09/05/2024
Oncology
Sawsan Rashdan, MD
Videos
08/28/2024
Sawsan Rashdan, MD, shares the main findings from her study on the use of osimertinib plus consolidative stereotactic ablative radiation for treating patients with advanced EGFR-mutated non–small cell lung cancer (NSCLC).
Sawsan Rashdan, MD, shares the main findings from her study on the use of osimertinib plus consolidative stereotactic ablative radiation for treating patients with advanced EGFR-mutated non–small cell lung cancer (NSCLC).
Sawsan Rashdan, MD, shares the...
08/28/2024
Journal of Clinical Pathways

Advertisement

Matthew Davids, MD
Videos
08/28/2024
Matthew Davids, MD, discusses groundbreaking developments in the chronic lymphocytic leukemia treatment landscape, focusing on the latest data from the ongoing AMPLIFY and MAJIC studies.
Matthew Davids, MD, discusses groundbreaking developments in the chronic lymphocytic leukemia treatment landscape, focusing on the latest data from the ongoing AMPLIFY and MAJIC studies.
Matthew Davids, MD, discusses...
08/28/2024
Oncology
Matthew Cortese, MD
Videos
08/26/2024
Matthew Cortese, MD, discusses recent updates in the National Comprehensive Cancer Network guidelines for the treatment of chronic lymphocytic leukemia (CLL) and ongoing clinical trials in this space.
Matthew Cortese, MD, discusses recent updates in the National Comprehensive Cancer Network guidelines for the treatment of chronic lymphocytic leukemia (CLL) and ongoing clinical trials in this space.
Matthew Cortese, MD, discusses...
08/26/2024
Journal of Clinical Pathways

Advertisement